Literature DB >> 12912930

Methylation and prognosis: of molecular clocks and hypermethylator phenotypes.

Jean-Pierre J Issa.   

Abstract

Mesh：

Year:  2003        PMID： 12912930

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  17 in total

1.  Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.

Authors:  H Itonaga; D Imanishi; Y-F Wong; S Sato; K Ando; Y Sawayama; D Sasaki; K Tsuruda; H Hasegawa; Y Imaizumi; J Taguchi; H Tsushima; S Yoshida; T Fukushima; T Hata; Y Moriuchi; K Yanagihara; Y Miyazaki
Journal:  Leukemia       Date:  2014-01-10       Impact factor: 11.528

Review 2.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Authors:  Federica Zoratto; Luigi Rossi; Monica Verrico; Anselmo Papa; Enrico Basso; Angelo Zullo; Luigi Tomao; Adriana Romiti; Giuseppe Lo Russo; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-03-28

Review 3.  DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.

Authors:  Nongnit Laytragoon-Lewin; Lars Erik Rutqvist; Freddi Lewin
Journal:  Med Oncol       Date:  2013-07-04       Impact factor: 3.064

Review 4.  Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Authors:  Zdenko Herceg; Pierre Hainaut
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

5.  Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.

Authors:  Rui-Lan Huang; Fei Gu; Nameer B Kirma; Jianhua Ruan; Chun-Liang Chen; Hui-Chen Wang; Yu-Ping Liao; Cheng-Chang Chang; Mu-Hsien Yu; Jay M Pilrose; Ian M Thompson; Hsuan-Cheng Huang; Tim Hui-Ming Huang; Hung-Cheng Lai; Kenneth P Nephew
Journal:  Epigenetics       Date:  2013-05-10       Impact factor: 4.528

6.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

Authors:  Lanlan Shen; Minoru Toyota; Yutaka Kondo; E Lin; Li Zhang; Yi Guo; Natalie Supunpong Hernandez; Xinli Chen; Saira Ahmed; Kazuo Konishi; Stanley R Hamilton; Jean-Pierre J Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

7.  Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.

Authors:  Heike Kroeger; Jaroslav Jelinek; Marcos R H Estécio; Rong He; Kimie Kondo; Woonbok Chung; Li Zhang; Lanlan Shen; Hagop M Kantarjian; Carlos E Bueso-Ramos; Jean-Pierre J Issa
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

8.  IGF-II promoter methylation and ovarian cancer prognosis.

Authors:  A C Beeghly; D Katsaros; A L Wiley; I A Rigault de la Longrais; A T Prescott; H Chen; M Puopolo; T J Rutherford; H Yu
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-14       Impact factor: 4.553

9.  Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.

Authors:  Sondes Karray-Chouayekh; Fatma Trifa; Abdelmajid Khabir; Nouredine Boujelbane; Tahia Sellami-Boudawara; Jamel Daoud; Mounir Frikha; Rachid Jlidi; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-06       Impact factor: 4.553

10.  Clinical and molecular models of glioblastoma multiforme survival.

Authors:  Stephen R Piccolo; Lewis J Frey
Journal:  Int J Data Min Bioinform       Date:  2013       Impact factor: 0.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.